• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Enhabit Home Health & Hospice Announces Date of 2023 Third Quarter Earnings Call; Comments on Limited Waiver and Liquidity

    10/4/23 4:41:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today provided updates on the timing for release of its results for the third quarter ended Sept. 30, 2023, and certain other matters.

    The Company is in the process of closing its books for the third quarter ended Sept. 30, 2023, and will report its results on Nov. 7, 2023, and host a webcast and conference call on Nov. 8, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

    • Nov. 8, 2023
    • 10:00 a.m. Eastern
    • Toll-free: 888-660-6150
    • International: 929-203-0843
    • Conference ID: 5248158
    • Internet website: https://events.q4inc.com/attendee/923162031

    A link to the webcast of the conference call and online replay can be found on Enhabit's investor website.

    Other information

    As previously announced on a Form 8-K filed on Oct. 2, 2023, the Company entered into a Limited Waiver dated Sept. 29, 2023, with Wells Fargo Bank, National Association, as administrative agent under its existing Credit Agreement. Also as previously announced, Enhabit has launched a process to review strategic alternatives. Since the announcement, the Company has been working diligently with its advisors on this review process, and the process is ongoing. With respect to the Limited Waiver announced in the Form 8-K, Company President and Chief Executive Officer Barb Jacobsmeyer said, "As we work with our advisors and prospective strategic partners as part of our strategic review, out of an abundance of caution we chose to proactively reach out to our bank group to ensure we remain in compliance with our financial covenants." At this time, the Company believes it has adequate liquidity. The Company has not drawn on its revolving credit facility in 2023. As of Sept. 30, 2023, the Company had total available liquidity of approximately $80 million, including cash and cash equivalents.

    About Enhabit Home Health & Hospice

    Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 255 home health locations and 108 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

    Forward-looking statements

    Statements contained in this press release which are not historical facts, such as those relating to the status of our strategic alternatives review process and our current liquidity position and other future events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking information speaks only as of the date hereof, and Enhabit undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from our present expectations include, but are not limited to, our ability to execute on our strategic plans, regulatory and other developments impacting the markets for our services, changes in reimbursement rates, general economic conditions, our ability to attract and retain key management personnel and healthcare professionals, potential disruptions or breaches of our or our vendors' information systems, the outcome of litigation, our ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures, our ability to control costs, particularly labor and employee benefit costs and our ability to successfully pursue and complete a strategic transaction. Our Form 10-K and subsequent quarterly reports on Form 10-Q, each of which can be found on the Company's website at http://investors.ehab.com and the SEC's website at www.sec.gov, discuss other risks and factors that could cause actual results to differ materially from those expressed or implied by any forward-looking statement in this press release. We urge you to consider all of the risks, uncertainties and factors identified above or discussed in such reports carefully in evaluating the forward-looking statements in this press release.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231004765575/en/

    Get the next $EHAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    3/6/2026$13.80Buy → Hold
    TD Cowen
    1/22/2026$14.00Perform → Outperform
    Oppenheimer
    1/13/2026$12.00Hold → Buy
    TD Cowen
    1/8/2026$12.00Neutral → Buy
    UBS
    1/7/2026$10.50Hold
    Truist
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    More analyst ratings

    $EHAB
    SEC Filings

    View All

    SEC Form PREM14A filed by Enhabit Inc.

    PREM14A - Enhabit, Inc. (0001803737) (Filer)

    3/30/26 9:02:50 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Enhabit Inc.

    SCHEDULE 13G/A - Enhabit, Inc. (0001803737) (Subject)

    3/26/26 6:22:16 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Enhabit Inc.

    144 - Enhabit, Inc. (0001803737) (Subject)

    3/11/26 3:58:29 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enhabit Reports Fourth Quarter 2025 Financial Results

    Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $270.4 million

    3/4/26 4:10:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit to be Acquired by Kinderhook Industries

    Enhabit, Inc. Stockholders to Receive $13.80 per Share in Cash Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC ("Kinderhook"), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately 24.4% to the Company's closing stock price on February 20, 2026, the last full trading day prior to the announcement of the transaction, and a 33.8% premium to the Compan

    2/23/26 8:00:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, 2026, and host a webcast and conference call on March 5, 2026. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 5, 2026 9 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/846254002 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit

    2/12/26 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enhabit Inc. downgraded by TD Cowen with a new price target

    TD Cowen downgraded Enhabit Inc. from Buy to Hold and set a new price target of $13.80

    3/6/26 8:25:46 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Enhabit Inc. from Perform to Outperform and set a new price target of $14.00

    1/22/26 8:46:17 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by TD Cowen with a new price target

    TD Cowen upgraded Enhabit Inc. from Hold to Buy and set a new price target of $12.00

    1/13/26 8:41:29 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Schochet Barry P.

    4 - Enhabit, Inc. (0001803737) (Issuer)

    4/13/26 9:55:42 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Rush Gregory S

    4 - Enhabit, Inc. (0001803737) (Issuer)

    4/13/26 9:54:28 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Rodgers Stephan

    4 - Enhabit, Inc. (0001803737) (Issuer)

    4/13/26 9:53:41 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Solomon Ryan bought $76,400 worth of shares (10,000 units at $7.64), increasing direct ownership by 5% to 193,468 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    8/11/25 6:30:04 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Bolton Jeffrey bought $34,760 worth of shares (4,000 units at $8.69), increasing direct ownership by 4% to 98,144 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/12/24 5:01:19 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Mcguigan Stuart M bought $132,150 worth of shares (15,000 units at $8.81), increasing direct ownership by 47% to 46,810 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/11/24 5:56:33 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Financials

    Live finance-specific insights

    View All

    Enhabit Reports Fourth Quarter 2025 Financial Results

    Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $270.4 million

    3/4/26 4:10:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit to be Acquired by Kinderhook Industries

    Enhabit, Inc. Stockholders to Receive $13.80 per Share in Cash Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC ("Kinderhook"), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately 24.4% to the Company's closing stock price on February 20, 2026, the last full trading day prior to the announcement of the transaction, and a 33.8% premium to the Compan

    2/23/26 8:00:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call

    Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, 2026, and host a webcast and conference call on March 5, 2026. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 5, 2026 9 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/846254002 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit

    2/12/26 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Leadership Updates

    Live Leadership Updates

    View All

    Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners

    On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court

    12/4/24 8:30:00 AM ET
    $EHAB
    $EHC
    Medical/Nursing Services
    Health Care
    Hospital/Nursing Management

    Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer

    Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl

    11/7/24 7:30:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    American Water Appoints New Independent Member to the Board of Directors

    American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan

    10/30/24 4:46:00 PM ET
    $AWK
    $EHAB
    Water Supply
    Utilities
    Medical/Nursing Services
    Health Care

    $EHAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Enhabit Inc.

    SC 13G - Enhabit, Inc. (0001803737) (Subject)

    11/14/24 9:12:39 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Enhabit Inc.

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    10/4/24 1:56:05 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Enhabit Inc. (Amendment)

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    2/13/24 5:04:31 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care